Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. News
    3. Search results
    Displaying results 51 - 75 of 643 Clear search
    Zyme Communications
    TrailBlazer StarBright Dye Label Kits
    Healthcare and Life Science 05 May 2026

    Bio-Rad expands range of TrailBlazer Kits for Antibody Conjugation to StarBright Dyes

    Expanded Range Increases Access to Bio-Rad’s StarBright™ Dyes for Flow Cytometry and Western Blot Applications in Immunology Research

    Zyme Communications
    Dr Simon Walsh, Chief Scientific Officer, Qureight,
    Healthcare and Life Science 05 May 2026

    Qureight establishes Scientific Advisory Board focused on pulmonary hypertension

     

    Zyme Communications
    The Lab Thread Unified Lab Software Platform
    Healthcare and Life Science 30 Apr 2026

    Lab Thread introduces Unified Lab Software Platform to streamline biological research

    Connects scientific teams, data and workflows within a single, fully integrated digital lab management system

    Zyme Communications
    Professor Dimitri Kullmann, Chief Scientific Officer of EpilepsyGTx
    Healthcare and Life Science 29 Apr 2026

    EpilepsyGTx appoints Professor Dimitri Kullmann as Chief Scientific Officer

    Appointment of UCL Neurologist will accelerate the delivery of novel gene therapies for refractory epilepsy

    Zyme Communications
    Bio-Rad logo
    Healthcare and Life Science 28 Apr 2026

    Bio-Rad launches PTC Harmony 96 and PTC Harmony Deepwell Thermal Cyclers

    New PTC Harmony Thermal Cycler Line Expands Access to Reliable, High-Performance PCR Across Academic and Biopharma Laboratories

    Zyme Communications
    Martin Stapleton, Chairman, PlaqueTec
    Healthcare and Life Science 27 Apr 2026

    PlaqueTec closes $5 million financing

    Oversubscribed round backed by existing shareholders Investment will support development of cardiovascular disease database to be used to inform patient stratification and therapeutic development programmes

    Cambridge, UK, 27 April 2026:

    Zyme Communications
    STORganoid™ ambient-temperature preservation solution for organoids and spheroids
    Healthcare and Life Science 21 Apr 2026

    Atelerix launches STORganoid cryo-free preservation solution for complex 3D cell models

    Ambient-temperature preservation solution enables reliable storage and shipment of organoids and spheroids, to support growing adoption of New Approach Methodologies 

    Zyme Communications
    Atelerix
    Healthcare and Life Science 15 Apr 2026

    Atelerix forms strategic partnership with JH Health Ltd to expand non-cryogenic cell preservation capabilities in the Middle East

    Agreement grants JH Health exclusive rights to use and distribute Atelerix’s portfolio of non-cryogenic preservation solutions in the regionExpands regional capabilities with funding for high-volume local manufacturing, as well as relevant regulatory filings and researc
    Zyme Communications
    bio-rad
    Healthcare and Life Science 14 Apr 2026

    Bio-Rad extends range of anti-idiotypic antibodies and anti-Fc mutation antibodies for bioanalysis and drug monitoring

    Expanded antibody portfolio enhances detection of biologics and YTE-modified therapeutics for bioanalytical applications

    Zyme Communications
    BioUK logo
    Healthcare and Life Science 14 Apr 2026

    OBN rebrands to BioUK in alignment with its mission to catalyse success in UK life sciences

    ·        The new name reflects the national reach of the UK life science membership organisation and leverages its wide and long-established portfolio of Bio-prefixed events 

    Zyme Communications
    Transmission Electron microscopic image of Mpox virus particles Credit: CDC/ National Institute of Allergy and Infectious Diseases (NIAID)
    Healthcare and Life Science 14 Apr 2026

    ProImmune collaborates with The University of Texas Medical Branch to Advance Infectious Disease Research

    Development of novel Ankyrons will enable study of emerging high-consequence infectious diseases to inform vaccines and treatments

    Zyme Communications
    Michael Lukesch, Founder and CEO at VALANX Biotech. Dr Klaus Orlinger, Chief Scientific Officer at VALANX Biotech.  Dr John Lambert, Chair of the Scientific Advisory Board at VALANX Biotech
    Healthcare and Life Science 14 Apr 2026

    VALANX Biotech establishes Scientific Advisory Board to advance ADC therapeutics

    John Lambert, Morris Rosenberg and Peter de Waele appointed as Chair and members of the SAB respectivelySAB provides scientific expertise and drug development experience, supporting advancement of the Company’s GoldenSite™ conjugation platform and its LIV-1 targeting le
    Zyme Communications
    SPT Labtech’s firefly®+ in use at EMBL GeneCore
    Healthcare and Life Science 13 Apr 2026

    SPT Labtech and EMBL GeneCore collaborate to advance fully walkaway automation in genomics workflows

    firefly+ liquid handling platform installed at EMBL GeneCoreCollaboration to enable more streamlined end-to-end workflows while maintaining sample integrity

    Cambridge, UK, and Heidelberg, Germany, 13 April 2026: SPT Labtech, a global le

    Zyme Communications
    FairJourney Bio
    Healthcare and Life Science 13 Apr 2026

    FairJourney Bio opens Cryo-EM structural biology facility in San Diego

    Antibody discovery expert expands presence in US biotech ecosystem with world-leading atomic-resolution structural biology capabilities

     

    Zyme Communications
    Carterra
    Healthcare and Life Science 09 Apr 2026

    William Blair analysts name Carterra a winner in life science tools for enabling AI drug discovery at unprecedented scale

    Carterra, with its HT-SPR technology platforms, is listed alongside large public companies as a technology provider to capitalize on the likely growth in wet lab work driven by the increasing use of AI in early discovery

    Zyme Communications
    Virica Biotech
    Healthcare and Life Science 09 Apr 2026

    Virica Biotech and FUJIFILM Biosciences Collaborate Under the Canada–Japan Co-Innovation Program to Advance AAV Production Enhancers

    Efficient production of Adeno-Associated Virus (AAV) vectors at scale for in vivo gene therapies remains a key bottleneck for broad patient access and sustainable manufacturing costs 

    Zyme Communications
    Sapna Vyas, Head of Scientific Programs at Axol Bioscience
    Healthcare and Life Science 31 Mar 2026

    PRISM ALS: New stem cell models could transform research into treatments for MND/ALS

    PRISM ALS is a new global initiative designed to accelerate the discovery of effective treatments for ALS/MND by improving access to specially grown, patient-derived stem cell models that better reflect the biological diversity of the disease. The collaboration brings t
    Zyme Communications
    Broken String Biosciences Rebrands
    Healthcare and Life Science 31 Mar 2026

    Broken String Biosciences rebrands to reflect strategic evolution as demand grows for unbiased genome-wide off-target analysis

    Rebrand follows appointment of new leadership as company drives commercialization of INDUCE-seq platform to address regulatory gaps in off-target reporting for gene editing programs

    Zyme Communications
    iXCells Biotechnologies
    Healthcare and Life Science 24 Mar 2026

    iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids

    Joint initiative with Rosebud Biosciences, Kantify, and funded by Incite will identify and quantify off-target toxicities in chemotherapy patientsDevelopment of patient-specific human organoids models for heart, liver, and kidney tissues

    San Die

    Zyme Communications
    An example of the visual output provided by the new QuanSA PyMOL plugin. m32 is approximately 50 times more potent than the structurally similar m01, despite having near identical patterns of hydrogen bonding (red and blue cones). The difference is explained by additional steric contributions indicated by the surface patches highlighted by the black arrows.
    Healthcare and Life Science 24 Mar 2026

    Optibrium Introduces Graphical Interface for QuanSA to Enhance Ligand-Based Affinity Predictions

    New user interface provides visual insights to guide compound optimisation

    Zyme Communications
    SLAS - Society for Laboratory Automation and Screening
    Healthcare and Life Science 23 Mar 2026

    SLAS announces the cohort for Innovation AveNEW at SLAS Europe 2026

    Vienna, Austria, 23 March 2026: SLAS, the Society of Laboratory Automation and Screening, has introduced the 12 companies selected for the Innovation AveNEW program at SLAS Europe 2026 Conference and Exhibition, taking place 19-21 May in Vienna, Austria.

    Zyme Communications
    logo
    Healthcare and Life Science 18 Mar 2026

    ProImmune and the Roslin Institute collaborate to advance animal health science

    Partnership will validate high quality, species specific Ankyron binders for key animal health science applications, including prevention and monitoring of zoonotic diseases

    Zyme Communications
    DNA Script’s SYNTAX® platform
    Healthcare and Life Science 18 Mar 2026

    DNA Script expands global access to on-demand DNA synthesis with distributor agreements in Latin America and East Asia

    Enables researchers worldwide to access high-quality ssDNA oligonucleotides within hoursEstablishes direct distribution networks across Latin America, Japan and South Korea

    Paris, France, 17 March 2026: DNA Script, a pioneer in DNA synt

    Zyme Communications
    Deyan Sultov, Co-founder and CTO (Left), and Dr Ryan Cawood, Co-founder and CEO (Right)
    Healthcare and Life Science 16 Mar 2026

    Lab Thread launches free version of Unified Lab Software Platform to accelerate academic research

    Free-to-use software version available for academic and non-profit researchers worldwideIntuitive system provides robust data management tools to support scientific collaboration and engagement with funding bodies through streamlined adherence to FAIR data principles
    Zyme Communications
    VALANX Biotech
    Healthcare and Life Science 12 Mar 2026

    VALANX Biotech secures €3 million to advance LIV-1 ADC for metastatic triple-negative breast cancer

    ·        Foundation Fournier-Majoie and FUJIFILM Corporation join existing VC and angel investors including xista science ventures, tecnet equity and SOSV

    Pagination

    • First page «
    • Previous page ‹
    • Page 1
    • Page 2
    • Current page 3
    • Page 4
    • Page 5
    • …
    • Next page ›
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS